Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Shares Outstanding (2016 - 2025)

Traws Pharma's Shares Outstanding history spans 14 years, with the latest figure at $6737.0 for Q4 2025.

  • Quarterly results put Shares Outstanding at $6737.0 for Q4 2025, down 99.82% from a year ago — trailing twelve months through Dec 2025 was $6737.0 (down 99.82% YoY), and the annual figure for FY2025 was $6737.0, down 99.82%.
  • Shares Outstanding for Q4 2025 was $9.1 million at Traws Pharma, up from $6737.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $21.0 million in Q1 2023 to a low of $6737.0 in Q3 2025.
  • The 5-year median for Shares Outstanding is $6.1 million (2025), against an average of $9.5 million.
  • Peak annual rise in Shares Outstanding hit 598.27% in 2025, while the deepest fall reached 99.82% in 2025.
  • Year by year, Shares Outstanding stood at $20.9 million in 2021, then crashed by 95.99% to $837040.0 in 2022, then grew by 0.38% to $840251.0 in 2023, then surged by 334.48% to $3.7 million in 2024, then plummeted by 99.82% to $6737.0 in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $6737.0, $6737.0, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.